From July 12 to 13, 2025, the “First Academic Annual Meeting of the Consciousness Disorder Rehabilitation Professional Committee of Hunan Province Association of Rehabilitation Medicine and Xiaoxiang Expert Forum on New Progress in the Treatment of Acute Brain Injury” hosted by Hunan Province Association of Rehabilitation Medicine and undertaken by Hunan Brain Hospital was successfully held in Changsha. IntelliMicro brought its self-developed IntelliMicro® Intracranial Pressure Monitoring System to the event. With its innovative digital signal transmission technology and integrated innovative design of “pressure measurement - temperature measurement - drainage”, the system became the focus of the venue and was highly praised by the participating experts, marking an important breakthrough in the core technology of domestic high-end intracranial pressure monitoring equipment.
Expert In-depth Analysis: Domestic Products Comparable to Imports With Far-reaching Clinical Significance
During the core academic forum of the conference, two authoritative experts of Hunan Provincial Brain Hospital, Professor Huang Hongxing, Academic advisor of the Neurosurgery Department, and Professor Li Xin, Director of the Neurosurgery Department, both used the IntelliMicro® Intracranial Pressure Monitoring System as an example to deeply discuss the significant value of intracranial pressure monitoring technology in clinical decision-making.
Professor Huang Hongxing emphasized in his keynote report The Clinical Guiding Value of Intracranial Pressure Monitoring Technology: Intracranial pressure monitors are widely used in clinical practice, not only for cranial trauma, acute brain injury and intensive care, but also for the diagnosis and treatment of various brain diseases such as brain hemorrhage, brain tumors. From the clinical perspective, we often prefer invasive intracranial pressure monitors with drainage functions. However, in the past, such devices could only be imported and were prohibitively expensive, making it difficult for them to enter the medical insurance system and benefit the patients over the long term. The emergence of IntelliMicro® has changed this situation, allowing patients to access high-performance domestic devices that are comparable to advanced foreign products.
Professor Li Xin, combines his report Precise Guidance for Clinical Treatment of Acute Brain Injury through Intracranial Pressure Numeric Representation and the actual clinical application of the IntelliMicro® Intracranial Pressure Monitoring System, he points out that the performance of IntelliMicro® Intracranial Pressure Monitoring System has reached the technological level of advanced foreign counterparts, achieving a triple integration of “surgical safety,” “data accuracy,” and “clinical efficiency.” Its innovative design not only reduces operational risks but also provides high-quality, continuous intracranial pressure data, which offers a solid basis for the individualized and refined treatment of neurocritical patients, significantly promoting the enhancement of standards in neurocritical care.
Breakthrough in Core Technologies: Multi-dimensional Advantages Establishing a New Benchmark for Domestic Monitoring
In the innovative product display area of the conference, engineers from IntelliMicro provided a professional demonstration, thoroughly explaining the technological innovations and clinical significance of the IntelliMicro® Intracranial Pressure Monitoring System.
The innovations of IntelliMicro® are reflected across multiple dimensions:
①With the enhanced anti-interference capability：the device adopts the innovative digital signal transmission architecture and can capture subtle intracranial changes;
②The device has an ultra-minimally invasive and safe design：with a sensor catheter diameter of only 0.7mm, which can meet the bending of multiple angles and effectively reduce the risk of surgery;
③The device is multi-functional and integrated with the three major functions：pressure measurement, temperature measurement, and drainage;
④The device has high degree of intelligence：with smart sound and light alarms, and the sensor kit has a built-in memory chip, which can automatically record the zero-point information and implantation time;
⑤The stability and reliability of the device is excellent：with a zero-point drift value of ≤2mmHg within 7 days of implantation, which ensures the reliability of long-term monitoring.
Many experts and scholars present expressed that the IntelliMicro® system deeply integrates cutting-edge technological innovation with solutions to core clinical pain points, setting a new technical benchmark in the field of neurocritical care.
Collaborative Synergy of Industry, Academia, Research, and Medicine: Driving “Domestic Substitution” and Medical Inclusion
This conference serves not only as a platform for the collision of cutting-edge academic ideas but also as an important showcase for innovative achievements in domestically produced high-end medical devices. IntelliMicro® Intracranial Pressure Monitoring System, with its proprietary digital signal transmission technology and other core technologies, has successfully transformed from a technical “follower” to a technical “leader” in certain fields, and its clinical value has been unanimously recognized by authoritative experts.
IntelliMicro stated that the Company will continue to deepen the integration and innovation mechanism of “industry-academia-research-medicine”, increase research and development investments, and reinforce strategic partnerships with leading clinical experts and scientific research institutions. It is committed to accelerating the clinical transformation and widespread application of innovative technologies in the field of neurocritical care, consistently advance the “domestic substitution” strategy for high-end medical devices, providing more accurate and reliable monitoring technologies to benefit the vast number of patients, and making substantial contributions to the improvement of treatment standards for traumatic brain injuries and neurocritical illnesses in China.